Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma

Journal of the National Cancer Institute

Volumn 90, Issue 13, 1998, Pages 972-977

  Leong, Paul P ^a   Rezai, Banafsheh ^a   Koch, Wayne M ^a   Reed, Andre ^a   Eisele, David ^a   Lee, Ding Jen ^a   Sidransky, David ^a   Jen, Jin ^a,b   Westra, William H ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 3P; CHROMOSOME 9P; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LUNG NODULE; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PROGNOSIS; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 0032126912     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.13.972     Document Type: Article

References (34)

1. Colby T, Koss M, Travis W. Tumors metastatic to the lung. In: Colby T, Koss M, Travis W, editors. Atlas of tumor pathology - tumors of the lower respiratory tract. Washington (DC): Armed Forces Institute of Pathology, 1995:517-46.
2. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343-53.
3. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989;17:467-76.
4. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 1981;2:547-9.
5. Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994;74:1933-8.
6. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-54.
7. Askin FB. Something old? Something new? Second primary or pulmonary metastasis in the patient with known extrathoracic carcinoma [editorial]. Am J Clin Pathol 1993;100:4-5.
8. Adkins PC, Wesselhoeft CW Jr, Newman W, Blades B. Thoracotomy on the patient with previous malignancy: metastasis or new primary? J Thorac Cardiovasc Surg 1968;56:351-61.
9. Shepherd MP. Thoracic metastases. Thorax 1982;37:366-70.
10. Cahan WG, Shah JP, Castro EB. Benign solitary lung lesions in patients with cancer. Ann Surg 1978;187:241-4.
11. Maestro R, Gasparotto D, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 1993;53:5775-9.
12. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 1995;11:210-2.
13. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
14. van der Riet P, Karp D, Farmer E, Wei Q, Grossman L, Tokino K, et al. Progression of basal cell carcinoma through loss of chromosome 9p and inactivation of a single p53 allele. Cancer Res 1994;54:25-7.
15. Yang SP, Lin CC. Lymphangitic carcinomatosis of the lungs. The clinical significance of its roentgenologic classification. Chest 1972;62:179-87.
16. Warren S, Gates O. Multiple primary malignant tumor: a survey of the literature and a statistical study. Am J Cancer 1932;16:1358-414.
17. Rott T, Luzar B, Sorli J. Bronchopulmonary changes after laryngeal cancer treatment - differentiation between metastatic laryngeal and second primary cancer. Act Otolaryngol Suppl 1997;527:167-9.
18. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426-30.
19. Papac R. Distant metastases from head and neck cancer. Cancer 1984;53:342-5.
20. Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ, et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996;56:2224-8.
21. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD, et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma [published erratum appears in JAMA 1995; 273:1908]. JAMA 1995;273:558-63.
22. Bedi GC, Westra WH, Gabrielson E, Koch W. Sidranski D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56:2484-7.
23. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
24. Merlo A, Gabrielson E, Askin F, Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-2.
25. Pogrebniak HW, Pass HI. Initial and reoperative pulmonary metastasectomy: indications, technique, and results, Semin Surg Oncol 1993;9:142-9.
26. Slaughter D, Southwick H, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:953-68.
27. Massard G, Wihlm JM, Ameur S, Jung GM, Rouge C, Dumont P, et al. Association of bronchial and pharyngo-laryngeal malignancies. A reappraisal. Eur J Cardiothorac Surg 1996;10:397-402.
28. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 1995;26:251-61.
29. Scholes AG, Woolgar JA, Boyle MA, Brown JS, Vaughan ED, Hart CA, et al. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 1998;58:2003-6.
30. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-83.
31. Yang HK, Linnoila RI, Conrad NK, Krasna MJ, Aisner SC, Johnson BE, et al. TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. Int J Cancer 1995;64:229-33.
32. Kropveld A, van Mansfeld AD, Nabben N, Hordijk GJ, Slootweg PJ. Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients. Eur J Cancer B Oral Oncol 1996;32B:388-93.
33. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994;54:1152-5.
34. Beahrs OH, Henson DE, Hutter RV, Kennedy BJ. Handbook for staging of cancer. Philadelphia: Lippincott, 1993.